The one-pot Mannich condensation of resorcinarenes with piperazine and an excess of formaldehyde under high dilution conditions results in a helical cage, namely, a covalently linked dimer of two resorcinarenes connected via four piperazine bridges in yields ranging from 20 to 40%. The compounds were analyzed by NMR spectroscopy, ESI mass spectrometry, and single crystal X-ray diffraction. The helical cages can encapsulate small guest molecules by adapting the cavity volume by changing the helical pitch according to the guest size.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/ol100407f | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Full Conjugation in a Polymer with Non-conjugated Piperazine-2,5-dione Units via Energy-minimized Lactam-to-Lactim Tautomerization Enables Water-gated Transistor Fluoride Sensors.
Angew Chem Int Ed Engl
November 2024
Department of Chemical Engineering, Waterloo Institute for Nanotechnology (WIN), University of Waterloo, 200 University Ave West, Waterloo, Ontario, N2L 3G1, Canada.
Article Synopsis
- - Piperazine-2,5-dione (GA) is being used to create a new type of conjugated polymer, PIDHPTT, which is aimed at improving chemical sensing in organic electronics.
- - Within the polymer, GA changes from a non-conjugated form to a conjugated form, driven by energy minimization and enhanced π-conjugation—this phenomenon is noted as a "long-range vinylogous effect" that has only been seen in small molecules before.
- - PIDHPTT shows strong interactions with fluoride ions, leading to notable changes in optical and electronic properties, and demonstrates high sensitivity and selectivity in a water-gated field-effect transistor, highlighting its potential for practical applications in chemical
Assessment of risk factors for virological nonsuppression following switch to dolutegravir and lamivudine, or bictegravir, emtricitabine, and tenofovir alafenamide fumarate in a real-world cohort of treatment-experienced adults living with HIV.
PLoS One
November 2024
Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan City, Taiwan.
Conflicting data exists regarding the baseline determinants of virological nonsuppression outcomes in treatment-experienced people living with human immunodeficiency virus (PWH) switching to antiretroviral treatment (ART) with bictegravir/emtricitabine/tenofovir alafenamide fumarate (BIC/FTC/TAF) or dolutegravir/lamivudine (DTG/3TC) in Asia. This retrospective observational study, conducted at a designated HIV-care hospital from October 2019 to January 2023, aimed to address this gap. We assessed the odds of virological nonsuppression (VNS) at weeks 48 using logistic regression.
View Article and Find Full Text PDFDeep eutectic solvent combined with permeation enhancer strategy to convert tandospirone from oral to transdermal formulations improving drug bioavailability.
Eur J Pharm Biopharm
December 2024
Department of Pharmaceutical Sciences, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning 110016, China; College of Pharmacy, Yanbian University, 977 Gongyuan Road, Yanji, Jilin, 133002, China. Electronic address:
Tandospirone(Tan) is a commonly used drug for anxiety treatment. However, it has a significant first-pass effect and needs to be taken three times a day. To increase the bioavailability of the drug and reduce the number of administrations, this work amid to prepare a Tan patch that can be administered once a day by using the strategy of therapeutic deep eutectic solvent(THEDES) in cooperation with chemical permeation enhancer(CPE).
View Article and Find Full Text PDFTotal Synthesis of (+)-Brevianamides A and B.
Org Lett
December 2024
Department of Chemical Sciences, IISER Kolkata, Mohanpur Campus, Kalyani, Nadia 741 246, West Bengal, India.
(+)-Brevianamides A () and B () are distinguished by their unique bicyclo[2.2.2]diazaoctane structure and have captured the interest of synthetic chemists due to their fascinating array of biological activities.
View Article and Find Full Text PDFTrametinib in combination with hydroxychloroquine or palbociclib in advanced metastatic pancreatic cancer: data from a retrospective, multicentric cohort (AIO AIO-TF/PAK-0123).
J Cancer Res Clin Oncol
October 2024
Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
Article Synopsis
- Preclinical studies suggest that combining MEK inhibition with autophagy or CDK4/6 targeting may be beneficial for pancreatic cancer (PDAC) patients.
- A retrospective analysis of 34 patients treated with trametinib combined with hydroxychloroquine (THCQ) or palbociclib (TP) was conducted to evaluate the effectiveness of these regimens.
- Results showed that both combinations were ineffective, with most patients experiencing disease progression within a short time frame, highlighting the need for better treatment strategies for advanced PDAC with specific genetic mutations.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!